Enhancement of tumor response to γ-radiation by an inhibitor of cyclooxygenase-2 enzyme

被引：188

作者：

Milas, L

Kishi, K

Hunter, N

Mason, K

Masferrer, JL

Tofilon, PJ

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA

[2] Monsanto, Searle, Pharma Res & Dev, St Louis, MO USA

来源：

关键词：

D O I：

10.1093/jnci/91.17.1501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1501 / 1504

页数：4

共 24 条

[1] BRUNDA MJ, 1980, J IMMUNOL, V124, P2682
[2] FINNEY DJ, 1952, QUANTAL RESPONSE TOL
[3] FURUTA Y, 1988, CANCER RES, V48, P3008
[4] FURUTA Y, 1988, CANCER RES, V48, P3002
[5] Gorski DH, 1998, CANCER RES, V58, P5686
[6] 16,16-DIMETHYL PROSTAGLANDIN-E-2 INDUCES RADIOPROTECTION IN MURINE INTESTINAL AND HEMATOPOIETIC STEM-CELLS
HANSON, WR
AINSWORTH, EJ
[J]. RADIATION RESEARCH, 1985, 103 (02) : 196 - 203
[7] HANSON WR, 1987, PROSTAGLANDIN LIPID, P331
[8] Inhibition of metastases by anticoagulants
Hejna, M
Raderer, M
Zielinski, CC
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (01): : 22 - 36
[9] Herson J., 1975, Journal of Statistical Computation and Simulation, V3, P265, DOI 10.1080/00949657508810091
[10] PROSTAGLANDINS AND CANCER - A REVIEW OF TUMOR INITIATION THROUGH TUMOR-METASTASIS
HONN, KV
BOCKMAN, RS
MARNETT, LJ
[J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1981, 21 (05) : 833 - 864